Sonnet Biotherapeutics (SONN) Q3 2025 Earnings

13AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-5.52
-3.84
-2.17
-0.49

Details

Expected EPS
-0.49
Actual EPS
N/A
Surprise EPS
0.49
Surprise Percent
+100%

Description

Sonnet Biotherapeutics (SONN) will report earnings of for Q3 2025 on August 13, 2025.

0 Comments

Share your thoughts